Australia
-
-
Aspen Medical Products redefines trauma spinal support with innovative integrated system
AUSTRALIA — Aspen Medical Products has introduced the innovative VRTX System, marking a pivotal advancement in spinal support systems for post-operative and trauma care. This…
-
Mesoblast forced back to the drawing board after US FDA rejects its children’s stem cell medicine
USA— The United States Food and Drug Administration (US FDA), has requested for more data to support marketing approval for Mesoblast’s remestemcel-L, a regenerative medicine…
-
Revolutionary biomarkers transform prostate cancer diagnosis and treatment
AUSTRALIA —In a groundbreaking study, researchers at the University of South Australia (UniSA) have unveiled a cutting-edge discovery that could transform the landscape of prostate…
-
Sun Pharma to commercially launch Philogen’s skin cancer drug in Europe, Australia & New Zealand
INDIA – Sun Pharma is set to begin the commercialization of novel skin cancer drug, Nidlegy, across the territories of Europe, Australia, and New Zealand…
-
University of Sydney researchers discover new protein that hinders Covid-19
AUSTRALIA — University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the…
-
Australian firm Immutep extends partnership with Merck and Pfizer for cancer treatment
AUSTRALIA — Australia’s Immutep has extended a Clinical Trial Collaboration and Supply Agreement with Merck KGaA and Pfizer for a new Phase I clinical study…
-
BridgeWest Group acquires Pfizer’s injectable manufacturing facility in Australia
AUSTRALIA — Bridgewest Group, a global private investment firm focused on developing companies in life sciences, software, and deep technology, has bought the sterile injectable…
-
BioNTech signs research and manufacturing pact with Australia
AUSTRALIA – BioNTech SE, the German biotech that collaborated with Pfizer to develop a widely used COVID-19 vaccine, will establish research and manufacturing facilities in…
-
Luina Bio rebrands to AcuraBio following acquisition by Dr. Glenn Haifer and Ampersand Capital Partners
AUSTRALIA- Leading Australian biopharmaceutical company Luina Bio has rebranded to AcuraBio following its acquisition by Dr. Glenn Haifer and global healthcare private equity firm Ampersand…